Protocol GuidesJuly 4, 20269 min read

Building a Recovery Protocol: From Injury to Full Function

A practical guide to building a peptide recovery protocol: which compounds, in what order, for how long — from acute injury to chronic repair.

Recovery is the most popular entry point into peptides — and with good reason. The compounds are well-studied (by peptide standards), the mechanisms are well-understood, and the timeline to results is shorter than any other category. But recovery protocols fail more often from poor structure than from wrong compound choice.

Here's a framework for building one that works.

Acute vs Chronic: Different Protocols

An acute injury (sprained ankle, post-surgical repair, muscle tear) and a chronic condition (tendinopathy, recurring joint inflammation, slow-healing soft tissue) need different approaches:

Acute injury protocol: Start BPC-157 immediately at 250–500 mcg daily near the injury site. Add TB-500 at 2–5 mg twice weekly for systemic support. Run for 4–6 weeks and assess. The goal is accelerated healing during the natural repair window — you're amplifying the body's existing repair signals, not overriding them.

Chronic condition protocol: Start with BPC-157 alone for 2 weeks to establish tolerance and assess response. Add TB-500 in week 3 at 2.5 mg twice weekly. Run for 8–12 weeks. The goal is breaking through a stalled repair process — chronic injuries have settled into a low-grade inflammatory equilibrium that needs a stronger signal disruption.

The BPC-157 + TB-500 Pairing

These two compounds are complementary rather than redundant — which is why they're paired in the Recovery Stack.

BPC-157 drives local repair at the injury site: angiogenesis (new blood vessel formation), growth factor activation, fibroblast migration, and extracellular matrix remodeling. It's the "on-site construction crew."

TB-500 (a synthetic fragment of Thymosin Beta-4) works systemically: actin upregulation drives stem cell mobilization from bone marrow, and whole-body anti-inflammatory signaling reduces the systemic inflammatory load that blunts recovery. It's the "supply chain and logistics."

Run them together rather than sequentially — the mechanisms don't duplicate each other. The pre-mixed TB-500/BPC-157 combo vial is convenient but sacrifices independent dose adjustment. For gut-focused or nerve-repair cases where higher BPC-157 dosing is standard, separate vials give you that flexibility.

The Recovery Stack Tiers

The Personalized Peptides Recovery Stack uses a three-tier model:

Foundation — BPC-157 only. Best for first-time peptide users, single localized injuries, or GI-driven inflammation. Lowest complexity, lowest cost, broadest safety evidence.

Standard — BPC-157 + TB-500. The "Wolverine Stack." For athletes training through injury, post-surgical recovery, or chronic tendinopathy. The systemic TB-500 component adds whole-body anti-inflammatory depth that BPC-157 alone doesn't provide.

Topical add-on — BPC Spray. For users with skin, wound, or mucosal involvement. The spray delivers BPC-157 directly to mucosal surfaces — gut lining, oral cavity, respiratory tract — at concentrations injectable BPC-157 may not reach in those compartments. Additive, not a replacement.

Signs Your Protocol Is Working

Recovery peptides produce signals, not guarantees. Here's the typical timeline:

  • Week 1–2: Pain reduction and improved mobility. The injured area feels "less angry." Morning stiffness decreases. This is the inflammatory phase quieting down — don't mistake it for structural repair.
  • Week 4–6: Functional improvement. Range of motion returns. Training loads can increase without the same pain response. Gut applications show clear symptom relief by this point.
  • Week 8–12: Structural repair. Tissue quality improves. Scar formation is minimized. This is where chronic injuries show their most meaningful gains. Many users return to training loads or activities they had written off.

If you're not seeing progress by week 6, don't extend the cycle indefinitely — assess and switch. A common mistake is running a recovery peptide for 16 weeks hoping for a delayed response. If the mechanism is going to work, 6–8 weeks is enough time to see the signal.

For the full BPC-157 evidence review, see BPC-157: What the Research Actually Shows. For cycling strategy across categories, Cycling Peptides: A Protocol Framework. For how to verify the quality of the peptides you're buying, Peptide Safety: How to Evaluate Research Chemical Quality.